NDC 70710-1839-8
Nelarabine 5 mg/mL
Nelarabine · INJECTION
Nelarabine is an intravenous injection used to treat certain types of leukemia and lymphoma. It works by interfering with how cancer cells produce and use nucleosides, which are building blocks needed for cancer cells to grow and divide.
Key Facts
- Brand Name
- Nelarabine
- Generic Name
- Nelarabine
- NDC Code (Package)
70710-1839-8- NDC Code (Product)
70710-1839- Manufacturer
- Zydus Pharmaceuticals USA Inc.
- Strength
- 5 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA215037
- Drug Class
- Nucleoside Metabolic Inhibitor [EPC]
- Marketing Start
- 06/24/2022
Recall History
No Recall HistoryView Full Drug Page
Nelarabine — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.